Vaginal Slings Market

Global Vaginal Slings Market Size

The size of the global vaginal slings market was worth USD 1.30 billion in 2024. The global market is anticipated to grow at a CAGR of 5.2% from 2025 to 2033 and be worth USD 2.05 billion by 2033 from USD 1.37 billion in 2025.

A vaginal or urethral sling is a surgical procedure to treat stress urinary incontinence. Stress urinary incontinence happens when physical activity such as coughing, laughing, sneezing, running, or heavy lifting puts stress on your bladder, resulting in you leaking urine. This is not related to psychological stress. Stress urinary incontinence (SUI) affects 15-60% of women. Both young and elderly individuals are affected by this. This surgical procedure helps to close the urethra and bladder neck. The urethra is the tube that carries urine from the bladder to the outside. One of the most common surgeries is a Mid-urethral sling. A thin mesh strip is used to make the sling, and the surgeon will put it under your urethra in three methods. Each type takes about 30 minutes.

MARKET DRIVERS

The growing incidence of stress urinary incontinence, an increasing number of research activities, and the growing female geriatric population are primarily driving the vaginal slings market forward.

An increase in the number of hysterectomy cases, many women with early onset of menopause, and an increase in the obese population are further fuelling the growth of the vaginal slings market. The changing lifestyle and population change lead to increased cases of gynecological problems in younger females. Women are affected more than men. Factors such as weakening of pelvic floor muscles & urethral sphincters, urinary tract infection, menopause, pregnancy & childbirth lead to the development of urinary incontinence symptoms. In 2018, according to the United Nations, women accounted for 55% of the total global aged population and around 60% of those aged over 80 years. Urinary incontinence is more common in the geriatric population due to chronic conditions such as kidney, liver, and bladder infections.

High demand for single-incision surgeries, technologically advanced vaginal sling products, increasing public healthcare spending, launching technologies that permit minimally invasive treatment of urine incontinence, R&D activities to develop new products and technologies, and product designs are expected to favor the growth rate of the vaginal slings market to climb further during the forecast period. Vaginal mesh and Colpo suspension were traditional treatment methods used. However, these techniques are now replaced by mid-urethral slings, considered an efficient, safe, and effective procedure. In addition, these techniques are gaining popularity as they use minimum recovery and procedural time. Owing to all these procedure advantages, the global vaginal slings market vendors are experiencing promising growth possibilities.

MARKET RESTRAINTS

On the other hand, a lack of awareness regarding the availability of vaginal slings and the post-operative risks of vaginal sling surgeries are expected to restrict the vaginal slings market growth during the forecast period. Alternative treatments and women's fear of having surgery given the risk of sub-urethral slings. Alternative treatment drugs include anticholinergic, mirabegron, topical estrogen, alpha-blockers, and other products such as Transvaginal mesh used by doctors to repair damaged tissue in the bladder, which are further anticipated to hamper the market’s growth rate.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Vaginal Sling Market – By Type

• Tension-free vaginal tape (TVT) Slings
• Transobturator tape (TOT) Slings
• Single Incision Slings

Based on type, the transobturator tape slings segment dominated the vaginal slings market worldwide in 2022. This is due to decreased risk of bladder injury, bowel injury, and significant blood vessel injury, increasing prevalence of urinary incontinence in women, an increasing geriatric population, and efficacy equivalent to tension-free vaginal tape slings.

Global Vaginal Sling Market – By Urinary Incontinence

• Urge
• Stress
• Mixed

The stress urinary incontinence segment accounted for the leading share among all in the global vaginal slings market in 2022. SUI occurs when pelvic tissues and muscles, which usually support the bladder and urethra, become weak and allow the bladder to fall during bursts of physical activity. This lowering can prevent the urethra from working properly to control urine flow. But, again, this is mainly occurring in females than in men.

Global Vaginal Sling Market – By End-Users

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Based on the end-user, the hospital segment dominated the market in 2022owing to the large-scale utilization of vaginal slings and the increased preference of the senior population for surgical treatment of urinary incontinence in hospitals.

On the other hand, the ambulatory surgical centers segment is anticipated to grow at a healthy CAGR during the forecast period. The growth of this segment can be attributed to the growing awareness of patients on minimally invasive surgeries and an increasing number of vaginal sling surgeries performed in the ambulatory surgical centers market.

REGIONAL ANALYSIS

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa

Geographically, North America dominates the vaginal slings market throughout the forecast period due to the presence of a larger patient population, well-established insurance policies, advanced healthcare infrastructure availability, and the increasing geriatric population. In this region, the United States holds the largest market share among others. Based on a report from National Association for Incontinence, more than 25 million people in the United States experience bladder leakage daily, of which women hold a significant share. According to the statistics, the large patient population and high disposable income propel the market growth in the region.

The vaginal slings market in the Asia Pacific is expected to expand at a rapid pace, primarily due to improving healthcare infrastructure, technological advancements, and rising private and public investment in research in countries such as China, Japan, and India. China dominated the market, and India is predicted to have the largest share in the market. The regions have the largest share due to their high healthcare expenditures, and the wide availability of new slings such as vaginal mesh and micro vaginal slings further promote expansion. Additionally, insurance plans and the availability of advanced healthcare infrastructure are a few additional elements driving growth in this region.

Europe has enormous potential development benefits from the region's substantial healthcare spending budget. Increasing the frequency of urinary tract infections among women in the UK, the European vaginal slings market will generate a sizable revenue by 2028. Based on National Health Service, 3-6 million people in the UK suffer from urine incontinence. The incidence of this disease and the development of advanced tools for minimally invasive surgeries will outpace the anticipated timeline for the need for vaginal mesh sling procedures. With rising occurrences of stress urinary incontinence among women and the growth of the older female population susceptible to urinary incontinence, Germany has a 30 percent share of the Western European vaginal slings market in 2019.

TOP COMPANIES IN THIS MARKET

C. R. Bard, Inc., Boston Scientific Corporation, Coloplast, Medtronic plc, Promedon Group, Ethicon, Inc., Agency for Medical Innovations, Analytic Biosurgical Solution (ABISS), Betatech Medical, and Caldera Medical are some of the notable players in the vaginal slings market profiled in this report.

RECENT MARKET DEVELOPMENTS

• In November 2021, Caldera Medical announced its FDA clearance for its new Dasara TVez, an expansion to its Dasara Family of products.
• In 2018, Boston Scientific announced findings from a three-year Solyx stress urinary incontinence mesh trial.